Ted Schenkelberg | Managing Partner
Next Frontier Advisors

Mr. Ted Schenkelberg (MBA/MPH), for over 25 years experience working in the vaccine and global health field. Currently, Ted is a Managing Partner at Next Frontier Advisors (NFA), a strategic consulting firm advising foundations, companies, universities and philanthropies in the vaccines, biomedical and global health fields. At NFA, Ted has led efforts to catalyze work in the Alzheimer’s vaccine space. 

Previously, Ted served as Co-Founder, Chief Operating Officer and Chief Strategy Officer at the Human Immunome Project (formerly the Human Vaccines Project), a global NGO working to catalyze AI-based models of the immune system with collaborations. Prior, Ted led business planning at the International AIDS Vaccine Initiative (IAVI), an NGO operating in 21 countries which has raised over $1 billion for vaccine R&D. He also served as an Equity Analyst and member of the Investment Committee at Carnegie Capital, an asset management firm which oversaw $1 billion in management and administration. 

Ted currently serves as a board member at Doctors of the World USA, Vital Strategies and MesaNova Bio and previously served as a board member at the African Services Committee, and the Human Immunome Project European Foundation. Ted was trained at the Johns Hopkins (MPH) and University of Chicago (MBA). He has also held a post as a Visiting Scientist at the Harvard Chan School.